As described in last month's article, New Approach Methodologies (NAMs) and Non-Animal Technologies (NATs), like organoids or fish eggs, are transforming the landscape of biomedical research, toxicology, and drug development. By offering human-relevant insights while reducing or replacing animal use, they hold the promise of more ethical, predictive, and cost-effective science. So, what's limiting their scalability?IntroductionSample handlingImage analysisData recoveryConclusions & outlooksReferences Introduction Despite rapid advances, many NAMs and NATs remain difficult to scale. This is often due to manual processes, complex protocols, reliance on expert operators, and variability across labs.…